Skip to content
Ranked #29Desk pick
Gala Health

Women ready to commit to a year up front, who want a low compounded rate with a real brand-name Ozempic option on the same account.

semaglutide
From $69/mo
tirzepatide
From $99/mo
Before enrolling

No month-to-month price is published anywhere — both compounded rates are an annual plan billed once a year, the up-front total is not printed, and the site says monthly and 3-month plans exist without giving a price for either

vs
Ranked #395
NowPatient

Brand-name GLP-1 access without a compounded route.

semaglutide
$1,349/mobrand-name
tirzepatide
$1,069/mobrand-name
Before enrolling

Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)

Our review of Gala Health gives it 81/100 (B−), while our review of NowPatient gives it 59/100 (C). The score breakdown shows where each provider does better.

Desk Score, dimension by dimension

Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.

Gala Health

81/100

B−

Overall

NowPatient

59/100

C

Price transparency

62
38

State access

96
24

Molecule range

90
95

Onboarding speed

82
66

Support responsiveness

80
83

Licensing & trust

82
80

The spec sheet

Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.

FieldGala HealthNowPatient
SemaglutideFrom $69/mo
Full plan terms

From $69/mo (compounded; yearly plan billed once a year; up-front total not printed; monthly and 3-month plans exist but no price is printed for them; brand Ozempic from $1,299/mo)

$1,349/mobrand-name
Full plan terms

$1,349/mo (brand Wegovy)

TirzepatideFrom $99/mo
Full plan terms

From $99/mo (compounded; yearly plan billed once a year; up-front total not printed; monthly and 3-month plans exist but no price is printed for them)

$1,069/mobrand-name
Full plan terms

$1,069/mo (brand Mounjaro, promotional rate)

CoverageAll 50 states (no state list published)Not confirmed for NowPatient.
Brand-nameBrand-name option listedBrand-name option listed
Oral optionNot confirmed hereOral option listed
Best forWomen ready to commit to a year up front, who want a low compounded rate with a real brand-name Ozempic option on the same account.Brand-name GLP-1 access without a compounded route.
Desk Score81/100B−59/100C

The verdict

Desk pick — Gala Health

Gala Health has the higher Desk Score, but NowPatient may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.

Choose Gala Health if…

Women ready to commit to a year up front, who want a low compounded rate with a real brand-name Ozempic option on the same account.

From $69/mo sema · From $99/mo tirz · All 50 states (no state list published)

Choose NowPatient if…

Brand-name GLP-1 access without a compounded route.

$1,349/mo (brand-name) sema · $1,069/mo (brand-name) tirz

Assume any provider we list may compensate us. We may earn a referral commission at no extra cost to you, and compensation does not change the Desk Score.

Also here

CoreAge Rx leads the whole ranking at 94/100

Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.